daunorubicin has been researched along with Body Weight in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (52.38) | 18.7374 |
| 1990's | 9 (21.43) | 18.2507 |
| 2000's | 9 (21.43) | 29.6817 |
| 2010's | 2 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Cheng, J; Li, J; Liu, L; Wang, J; Wang, X; Wei, H; Wu, W; Xia, G; Xu, C; Xu, W; Yang, L; Yang, M; Zhang, Y | 1 |
| Klopotowska, D; Lukawska, M; Milczarek, M; Oszczapowicz, I; Porebska, A; Studzian, K; Szmigiero, L; Wietrzyk, J | 1 |
| Adamcová, M; Gersl, V; Hrdina, R; Klimtová, I; Mazurová, Y; Simůnek, T | 1 |
| Adamcová, M; Gersl, V; Hrdina, R; Kaplanová, J; Klimtová, I; Mazurová, Y; Simůnek, T; Sterba, M | 1 |
| Aizawa, Y; Kamal, FA; Kodama, M; Kunisaki, M; Ma, M; Mito, S; Palaniyandi, S; Prakash, P; Soga, M; Tachikawa, H; Veeraveedu, P; Watanabe, K | 1 |
| Adamcová, M; Gersl, V; Kaiserová, H; Mazurová, Y; Ponka, P; Popelová, O; Potácová, A; Simunek, T; Sterba, M | 1 |
| El-Hage, AN; Ferrans, VJ; Herman, EH; Witiak, DT | 1 |
| Bachmann, E; Beilstein, AK; Zbinden, G | 1 |
| Cangir, A; Obama, M; van Eys, J | 1 |
| Ardalan, B; Ferrans, VJ; Herman, EH; Jordan, W | 1 |
| Elrod, DW; Houser, DJ; Richard, FA; Wiley, PF | 1 |
| Finch, MD; Hellmann, K; Trevan, D; Wang, G | 1 |
| Henry, TR; Solem, LE; Wallace, KB | 1 |
| Bajgar, J; Gersl, V; Hrdina, R; Krs, O; Mazurová, Y; Palicka, V | 1 |
| Cerman, J; Gersl, V; Hrdina, R; Machácková, J; Mazurová, Y; Suba, P | 1 |
| Bajgar, J; Cerman, J; Gersl, V; Hrdina, R; Machácková, J; Mazurová, Y; Suba, P | 1 |
| Akiyoshi, K; Eguchi, H; Hara, T; Inada, H; Ishii, E; Koga, H; Matsuzaki, A; Miyazaki, S; Nagatoshi, Y; Nakayama, H; Nibu, K; Okamura, J; Take, H; Tamai, Y; Yanai, F | 1 |
| Arrigoni, C; Brughera, M; Della Torre, P; Imondi, AR; Moneta, D; Podestà, A; Sammartini, U; Terron, A | 1 |
| Bonoron-Adèle, S; Platel, D; Robert, J | 1 |
| Hishida, A; Kimura, M; Ohtake, T; Takemura, H | 1 |
| Bénard, J; Charpentier, B; Cherbonnier, C; Déas, O; Dürrbach, A; Haeffner, A; Hirsch, F; Merlin, JL; Senik, A; Vassal, G | 1 |
| Ardalan, B; Bier, C; Herman, E; Krop, S; Waravdekar, V | 1 |
| Mandelli, F | 1 |
| Frisch, H; Schuster, E; Thun-Hohenstein, L | 1 |
| Araki, Y; Gomita, Y; Shinozawa, S | 1 |
| Bogusová, TA; Hrdina, R; Kunová, A; Kvĕtina, J | 1 |
| Christadoss, P; Henderson, R; Keve, S | 1 |
| Ito, H; Ito, M; Naruse, A; Oguri, M; Satake, N; Shibata, S; Suzuki, Y | 1 |
| Hibi, N; Ohkawa, K; Tsukada, Y | 1 |
| Capizzi, RL; Chandrasekaran, B; Dimling, J | 1 |
| Ferrans, VJ; Herman, EH | 1 |
| Duncan, R; Hume, IC; Kopecek, J; Kopecková, P; Lloyd, JB; Strohalm, J | 1 |
| Gol'dberg, LE; Shepelevtseva, NG; Shevniuk, LA; Stepanova, ES; Vertogradova, TP | 1 |
| Chibowski, D; Chmielewska, B; Chodkowska, A; Kleinrok, Z; Rajtar, G; Sawiniec, Z; Siezieniewska, Z | 1 |
| Bligham, G; Freireich, EJ; Gehan, E; Hester, JP; Kantarjian, HM; Keating, MJ; McCredie, KB; Smith, TL; Talpaz, M; Walters, RS | 1 |
| Creighton, AM; el-Hage, AN; Ferrans, VJ; Herman, EH; Witiak, DT | 1 |
| Delamore, IW; Mir, MA | 1 |
| Cline, MJ; Haskell, CM | 1 |
| Casazza, AM; Di Marco, A; Lenaz, L; Scarpinato, BM | 1 |
| Begemann, H; Gerhartz, H | 1 |
| Fujimori, H; Kagino, K; Nomiya, B; Orikawa, Y | 1 |
| Farmar, RM; Herman, EH; Schein, P | 1 |
1 review(s) available for daunorubicin and Body Weight
| Article | Year |
|---|---|
Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Height; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Growth Disorders; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; Infant; Japan; Male; Methotrexate; Myelodysplastic Syndromes; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Survivors; Treatment Outcome; Vincristine | 2001 |
41 other study(ies) available for daunorubicin and Body Weight
| Article | Year |
|---|---|
Biocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignancies.
Topics: Analysis of Variance; Animals; Biocompatible Materials; Body Weight; Daunorubicin; Female; Hematologic Neoplasms; Hemolysis; Humans; Injections, Intraperitoneal; Lethal Dose 50; Magnetite Nanoparticles; Male; Mice; Micronucleus Tests | 2010 |
Oxazolinodoxorubicin - a promising new anthracycline.
Topics: Animals; Antibiotics, Antineoplastic; Body Weight; Cell Line, Tumor; Daunorubicin; Doxorubicin; Female; HL-60 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Inbred NOD; Mice, SCID; Xenograft Model Antitumor Assays | 2012 |
Comparative study of chronic toxic effects of daunorubicin and doxorubicin in rabbits.
Topics: Animals; Antibiotics, Antineoplastic; Body Weight; Clinical Chemistry Tests; Daunorubicin; Disease Models, Animal; Doxorubicin; Heart; Heart Failure; Heart Ventricles; Hemodynamics; Kidney; Male; Myocardium; Rabbits; Toxicity Tests, Chronic; Ventricular Dysfunction, Left | 2002 |
Rabbit model for in vivo study of anthracycline-induced heart failure and for the evaluation of protective agents.
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Biomarkers; Body Weight; Cardiovascular Agents; Daunorubicin; Disease Models, Animal; Dose-Response Relationship, Drug; Echocardiography; Erythrocyte Indices; Heart Failure; Heart Rate; Heart Ventricles; Male; Models, Cardiovascular; Myocardium; Myocytes, Cardiac; Rabbits; Razoxane; Stroke Volume; Time Factors | 2004 |
Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Calcium-Transporting ATPases; Cardiomyopathies; Cytoprotection; Daunorubicin; Disease Models, Animal; Electrocardiography; Fas Ligand Protein; Male; Membrane Glycoproteins; Organ Size; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Survival Rate; Tetrazoles; Tumor Necrosis Factors | 2006 |
Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity.
Topics: Animals; Antibiotics, Antineoplastic; Blood Pressure; Body Weight; Cardiac Output; Cardiotonic Agents; Cell Division; Chinchilla; Daunorubicin; Electrocardiography; Heart Diseases; Heart Rate; HL-60 Cells; Humans; Hydrazones; Iron Chelating Agents; Male; Myocardial Contraction; Myocardium; Pyridoxal; Rabbits; Stroke Volume; Troponin T; Ventricular Function, Left | 2006 |
Reduction by ICRF-187 of acute daunorubicin toxicity in Syrian golden hamsters.
Topics: Animals; Body Weight; Cricetinae; Daunorubicin; Male; Mesocricetus; Piperazines; Razoxane; Time Factors | 1983 |
Toxicological studies with a novel synthetic anthracycline, the bis-hydrazone bridged analog of 4-demethoxydaunorubicin (SC-33428).
Topics: Animals; Antineoplastic Agents; Blood Cell Count; Body Weight; Daunorubicin; Doxorubicin; Electrocardiography; Female; Idarubicin; Leukopenia; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Nutritional status and anthracycline cardiotoxicity in children.
Topics: Antibiotics, Antineoplastic; Body Height; Body Weight; Cardiomyopathies; Child; Daunorubicin; Doxorubicin; Electrocardiography; Humans; Naphthacenes; Nutrition Disorders; Retrospective Studies | 1983 |
Reduction of chronic daunorubicin cardiotoxicity by ICRF-187 in rabbits.
Topics: Animals; Antineoplastic Agents; Blood Chemical Analysis; Body Weight; Calcium; Daunorubicin; Heart; Male; Myocardium; Piperazines; Rabbits; Razoxane | 1981 |
Structure--activity relationships of nogalamycin analogues.
Topics: Animals; Body Weight; Chemical Phenomena; Chemistry; Daunorubicin; Leukemia L1210; Leukemia P388; Mice; Nogalamycin; Structure-Activity Relationship | 1982 |
Reduction of daunomycin toxicity by razoxane.
Topics: Animals; Body Weight; Daunorubicin; Dose-Response Relationship, Drug; Female; Intestines; Mice; Piperazines; Razoxane | 1981 |
Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration.
Topics: Analysis of Variance; Animals; Body Weight; Calcium; Cyclosporine; Daunorubicin; Doxorubicin; Homeostasis; Male; Membrane Potentials; Mitochondria, Heart; Mitochondrial Swelling; Organ Size; Oxygen Consumption; Rats; Rats, Inbred F344; Ruthenium Red; Time Factors | 1994 |
Changes in cholinesterase activities after daunorubicin administration to rabbits.
Topics: Acetylcholinesterase; Animals; Antibiotics, Antineoplastic; Body Weight; Butyrylcholinesterase; Cardiomyopathies; Daunorubicin; Heart Ventricles; Liver; Male; Myocardium; Rabbits; Tissue Preservation | 1996 |
IGF-I in experimental daunorubicin-induced cardiomyopathy in rabbits.
Topics: Animals; Body Weight; Cardiomyopathy, Dilated; Daunorubicin; Heart; Heart Ventricles; Hemodynamics; Insulin-Like Growth Factor I; Liver; Male; Muscle, Skeletal; Myocardium; Rabbits; Tissue Distribution | 1999 |
Cholinesterases in dexrazoxane-treated daunorubicin cardiomyopathy in rabbits.
Topics: Acetylcholinesterase; Animals; Antibiotics, Antineoplastic; Body Weight; Butyrylcholinesterase; Cardiomyopathies; Cardiovascular Agents; Daunorubicin; Heart; Male; Myocardium; Rabbits; Razoxane; Ventricular Function, Left | 1999 |
PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential.
Topics: Animals; Antibiotics, Antineoplastic; Body Weight; Bone Marrow Diseases; Daunorubicin; Doxorubicin; Female; Heart Diseases; Leukocyte Count; Male; Organ Size; Rats; Rats, Sprague-Dawley | 2001 |
Role of daunorubicinol in daunorubicin-induced cardiotoxicity as evaluated with the model of isolated perfused rat heart.
Topics: Animals; Antibiotics, Antineoplastic; Blood Pressure; Body Weight; Daunorubicin; Diastole; Dose-Response Relationship, Drug; Heart; In Vitro Techniques; Injections, Intraperitoneal; Male; Models, Cardiovascular; Myocardial Contraction; Perfusion; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Pressure | 2001 |
Effects of dietary lipids on daunomycin-induced nephropathy in mice: comparison between cod liver oil and soybean oil.
Topics: Albuminuria; Animals; Body Weight; Cod Liver Oil; Daunorubicin; Dietary Fats; Dinoprost; Glutathione; Kidney; Kidney Diseases; Lipid Peroxides; Male; Mice; Mice, Inbred Strains; Soybean Oil; Thromboxane B2 | 2002 |
Human growth hormone gene transfer into tumor cells may improve cancer chemotherapy.
Topics: Antibiotics, Antineoplastic; Body Weight; Cell Death; Cell Nucleus; Combined Modality Therapy; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; Gene Transfer Techniques; Human Growth Hormone; Humans; Neoplasms; NF-kappa B; Time Factors; Transfection; Tumor Cells, Cultured; U937 Cells | 2002 |
Reduction of daunorubicin lethality and myocardial cellular alterations by pretreatment with ICRF-187 in Syrian golden hamsters.
Topics: Animals; Body Weight; Chemical and Drug Induced Liver Injury; Cricetinae; Daunorubicin; Heart Diseases; Liver; Liver Diseases; Male; Mesocricetus; Myocardium; Piperazines; Rats; Razoxane; Stereoisomerism; Time Factors | 1979 |
[Therapy of non-lymphoid acute leukemias].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Body Weight; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Middle Aged; Remission, Spontaneous; Thioguanine; Vincristine | 1975 |
Growth after radiotherapy and chemotherapy in children with leukemia or lymphoma.
Topics: Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Height; Body Weight; Child; Child, Preschool; Daunorubicin; Dose-Response Relationship, Radiation; Female; Growth; Humans; Lymphoma, Non-Hodgkin; Male; Multivariate Analysis; Pituitary Gland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Somatomedins; Vincristine | 1992 |
[Effects of anthracycline drugs (aclarubicin, daunorubicin, doxorubicin, epirubicin, pirarubicin) on mouse acute toxicity and rat liver microsomal lipid peroxidation].
Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Body Weight; Daunorubicin; Doxorubicin; Epirubicin; Lipid Peroxidation; Male; Mice; Mice, Inbred ICR; Microsomes, Liver; Mitochondria, Liver; Rats; Rats, Inbred Strains | 1992 |
Changes in the toxicity and therapeutic efficacy of daunorubicin linked with a biodegradable carrier.
Topics: Animals; Aza Compounds; Blood Pressure; Body Weight; Creatine Kinase; Daunorubicin; Drug Carriers; Drug Interactions; Female; Heart Rate; Injections, Intraperitoneal; Leukemia P388; Liver; Male; Mice; Mice, Inbred Strains; Nitriles; Peptides; Plasmacytoma; Pyrimidine Nucleosides; Sulfobromophthalein | 1991 |
Daunomycin treatment prevents clinical expression of experimental autoimmune myasthenia gravis.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Body Weight; Daunorubicin; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Myasthenia Gravis; Organ Size; Receptors, Cholinergic | 1991 |
Impaired endothelium-dependent relaxation in isolated thoracic aorta of rats with daunomycin-induced nephrosis.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Calcimycin; Daunorubicin; Endothelium; Injections, Intravenous; Male; Microscopy, Electron, Scanning; Muscle Relaxation; Muscle, Smooth, Vascular; Nephrosis; Nitric Oxide; Nitroprusside; Rats; Rats, Inbred Strains | 1991 |
Suppression of human alpha-foetoprotein-producing hepatocellular carcinoma growth in nude mice by an anti alpha-foetoprotein antibody-daunorubicin conjugate with a poly-L-glutamic acid derivative as intermediate drug carrier.
Topics: alpha-Fetoproteins; Animals; Antibodies; Antibodies, Neoplasm; Body Weight; Cytotoxicity, Immunologic; Daunorubicin; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Mitosis; Pharmaceutical Vehicles; Polyglutamic Acid | 1985 |
Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line; Daunorubicin; Doxorubicin; Drug Resistance; Leukemia P388; Life Expectancy; Menogaril; Mice; Mice, Inbred Strains; Mitoxantrone; Nogalamycin | 1987 |
Pretreatment with ICRF-187 provides long-lasting protection against chronic daunorubicin cardiotoxicity in rabbits.
Topics: Animals; Blood Cell Count; Body Weight; Cardiomyopathies; Daunorubicin; Drug Administration Schedule; Drug Interactions; Hemoglobins; Injections, Intraperitoneal; Injections, Intravenous; Male; Piperazines; Rabbits; Razoxane | 1986 |
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.
Topics: Acrylamides; Animals; Body Weight; Daunorubicin; Drug Carriers; Leukemia L1210; Male; Mice; Mice, Inbred DBA; Time Factors; Tissue Distribution | 1988 |
[Toxicity of rubomycin 13-cyclohexylidene hydrazone].
Topics: Animals; Body Weight; Daunorubicin; Dose-Response Relationship, Drug; Heart; Hematopoiesis; Lethal Dose 50; Mice; Structure-Activity Relationship; Time Factors | 1987 |
Comparison of subacute toxicity of rubidomycine and its four derivatives.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Proteins; Body Weight; Daunorubicin; Male; Mice; Organ Size; Structure-Activity Relationship | 1986 |
Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Basophils; Blood Cell Count; Body Weight; Bone Marrow Cells; Busulfan; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Combinations; Female; Hemoglobins; Humans; Hydroxyurea; Leukemia, Myeloid; Male; Middle Aged; Philadelphia Chromosome; Prednisone; Prognosis; Risk; Vincristine | 1985 |
Comparison of the protective effect of ICRF-187 and structurally related analogues against acute daunorubicin toxicity in Syrian golden hamsters.
Topics: Animals; Body Weight; Cricetinae; Daunorubicin; Male; Mesocricetus; Piperazines; Razoxane; Stereoisomerism; Structure-Activity Relationship | 1985 |
Hyponatraemia syndrome in acute myeloid leukaemia.
Topics: Adult; Ampicillin; Blood Cell Count; Body Weight; Bone Marrow Cells; Chlorides; Cloxacillin; Cytarabine; Daunorubicin; Diet; Female; Fever; Food Analysis; Gentamicins; Humans; Hyponatremia; Leukemia, Myeloid, Acute; Male; Middle Aged; Nitrogen; Osmolar Concentration; Potassium; Sodium; Syndrome; Urea | 1974 |
The treatment of acute leukemia.
Topics: Adolescent; Adult; Antimetabolites; Antineoplastic Agents; Asparaginase; Body Weight; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Gestational Age; Humans; Infant; Infant, Newborn; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Prednisone; Pregnancy; Remission, Spontaneous; Time Factors; Vincristine | 1974 |
Activity of adriamycin (NSC-123127) and daunomycin (NSC-82151) against mouse mammary carcinoma.
Topics: Amino Sugars; Animals; Antibiotics, Antineoplastic; Body Weight; Daunorubicin; Female; Glycosides; Injections, Intravenous; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Naphthacenes; Neoplasm Transplantation; Time Factors | 1972 |
Result of a cooperative study with L-asparaginase in human leukemias. Report of the section "oncology" of the Paul-Ehrlich-Society for Chemotherapy.
Topics: Asparaginase; Blood Chemical Analysis; Blood Platelets; Blood Sedimentation; Body Weight; Central Nervous System Diseases; Daunorubicin; Erythrocyte Count; Hepatomegaly; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Nausea; Splenomegaly; Time Factors; Vincristine; Vomiting | 1970 |
[Experimental studies on antineoplastic activity of daunomycin. I. Effect on experimental tumors].
Topics: Animals; Body Weight; Carcinoma, Ehrlich Tumor; Carcinosarcoma; Daunorubicin; Injections, Intraperitoneal; Leukemia, Experimental; Liver; Male; Mice; Mitomycins; Neoplasms, Experimental; Pancreas; Rats; Sarcoma 180; Solutions; Spleen | 1970 |
Pathologic changes induced by daunomycin (NSC-82151) in the Syrian golden hamster.
Topics: Animals; Body Weight; Cricetinae; Daunorubicin; Heart; Liver; Lung; Male; Myocardium | 1970 |